GeneDx Ownership | Who Owns GeneDx?
GeneDx Ownership Summary
GeneDx is owned by 69.51% institutional investors, 20.28% insiders, and 10.21% retail investors.
WGS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | GeneDx | 69.51% | 20.28% | 10.21% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Healthcare Information Services Stocks | 52.99% | 9.95% | 37.06% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 145 | 57.61% | 18,835,001 | 15.66% | 69 | 1.86% | 97 | 46.97% | 25 | 127.27% |
Jun 30, 2024 | 92 | 50.82% | 16,284,877 | 17.09% | 61 | 2.15% | 66 | 88.57% | 11 | 37.50% |
Mar 31, 2024 | 61 | 22.00% | 13,908,270 | 11.80% | 53 | 2.33% | 35 | 94.44% | 8 | -50.00% |
Dec 31, 2023 | 50 | -13.79% | 12,440,649 | -10.79% | 47 | 1.64% | 18 | -21.74% | 16 | -5.88% |
Sep 30, 2023 | 58 | -6.45% | 13,944,728 | -0.06% | 54 | 1.79% | 23 | -58.93% | 17 | 750.00% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 09, 2024 | Stueland Katherine | Chief Executive Officer | Sell | $279.60K |
Dec 09, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $86.84K |
Dec 02, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $20.62K |
Nov 21, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $77.16K |
Nov 21, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $30.46K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 36 |
2024 Q3 | - | 26 |
2024 Q2 | 7 | 7 |
2024 Q1 | 2 | 9 |
2023 Q4 | 3 | 11 |
WGS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools